Europe — EMA

Oprymea (Pramipexole Dihydrochloride Monohydrate)

Pramipexole dihydrochloride monohydrate, the active ingredient in Oprymea, is a dopamine agonist presented as a unknown/unknown for oral use. It treats symptoms of Parkinson's disease in adults.

Pramipexole Dihydrochloride Monohydrate

Request sourcing

Pack/s

What is Pramipexole Dihydrochloride Monohydrate?

Pramipexole dihydrochloride monohydrate, the active ingredient in Oprymea, is a dopamine agonist presented as a unknown/unknown for oral use. It treats symptoms of Parkinson's disease in adults. GNH USA supplies Oprymea as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oprymea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Pramipexole Dihydrochloride Monohydrate used for?

Oprymea (pramipexole) is a dopamine‑receptor agonist that works within the central nervous system .

- Parkinson's disease: Provides … … . - ....

What are the side effects of Pramipexole Dihydrochloride Monohydrate?

....

What precautions apply to Pramipexole Dihydrochloride Monohydrate?

....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →